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Highlights (no more than 85 characters including spaces per bullet) 
 
 Chronic non-cancer pain is common with over 100 million people affected. 
 There is little evidence that opioids are effective for long-term pain management. 
 Opioid prescribing for chronic pain is under increased scrutiny in the U.S.  
 Patient anxiety, catastrophizing, and alliance are associated with opioid talk.  
 Provider views on opioids, psychosocial role, and burnout linked with opioid talk. 
 
 
Abstract (200/200 words) 
Objective:  
Our objective is to examine the relationship of patient and provider characteristics and 
communication with chronic non-cancer pain and opioid management in primary care.  
Method:  
We conducted an observational study using audio-recorded primary care appointments 
(up to 3/patient) and self-reported assessments of primary care providers (PCPs) and 
patients. We coded visit transcripts for 1) opioid and pain management talk and 2) 
mental health and opioid safety talk.  
Results:  
Eight PCPs and 30 patients had complete data for 78 clinic visits. PCPs and patients 
engaged in more opioid and pain management talk when patients reported greater pain 
catastrophizing and PCPs reported higher psychosocial orientation. PCPs and patients 
engaged in talk about mental health and opioid safety when patients reported greater 
anxiety, higher working alliance with their PCP, and when PCPs reported higher 
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burnout. PCPs’ negative attitudes about opioids were associated with fewer discussions 
about mental health and opioid safety.  
Conclusions:  
Our results should facilitate design of interventions that improve communication and, 
ultimately, pain outcomes for patients.  
Practice Implications 
Clinicians can use our results to increase patient engagement in discussions about 
opioid use and pain management or mental health and safety discussions. 
 
 
Key words: opioids, pain, communication, provider-patient relationship 
 
1. Introduction 
Chronic pain is prevalent, affecting over 100 million Americans.[1] Use of opioid 
analgesics to treat chronic pain has increased substantially in recent years,[2,3] despite 
lack of evidence documenting the effectiveness of opioids for long-term pain 
management.[3,4] As public awareness of opioid-related harms has risen,[5,6] new 
clinical guidelines for safely prescribing opioids and for managing chronic pain have 
been developed.[7–9] A recent review of studies examining interventions to reduce or 
discontinue long-term opioid therapy found opioid reduction interventions may improve 
pain, quality of life, and function.[10] Moreover, a recent randomized controlled trial 
showed no advantage for opioids over non-opioids for patients with chronic pain over 12 
months.[11]  
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The harms associated with opioids, coupled with recent evidence calling into 
question their effectiveness for chronic pain; can introduce challenges in communicating 
about chronic pain and its treatment. Patients may be unaware of alternatives such as 
non-opioid pain relief and lifestyle approaches such as yoga that may be just as 
effective.[11,12] Given the importance of discussing harms versus benefits of opioids, 
and the need to discuss non-opioid treatment alternatives with patients, communication 
is a central aspect of chronic pain management and possibly addiction risk 
reduction.[13] Studies have sought to gain a greater understanding of communication 
about pain and opioids,[14–16] but a number of gaps remain. A recent review of studies 
on communication about pain identified the need not just to examine clinical 
communication, but to seek to understand contextual factors, such as patient and 
provider characteristics, attitudes, and beliefs, that might influence this 
communication.[17] We were guided by Street’s ecological model of communication in 
medical encounters. The ecological model emphasizes the role of clinician and patient 
context in understanding provider-patient communication.[18,19] Thus we assessed 
clinician factors such as attitudes, specialty, and age and patient factors such as 
education, gender, personality, diagnosis, and coping strategies. Finally, given the 
social context of the opioid crisis, we sought to examine communication that addressed 
opioid medications and safety, particularly because of the current environment in which 
patients, providers, and the general public are experiencing heightened awareness of 
opioid-related harms.  
Toward this end, we sought to examine primary care provider (PCP) and patient 
characteristics associated with discussions of pain and opioid management. 
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Understanding these characteristics will inform future interventions to optimize 
communication about pain and opioid management, potentially leading to more effective 
pain management and increased patient safety. We conducted an observational study 
of patients in primary care who were prescribed opioids for chronic pain. We 
hypothesized that patients who report greater pain, distress, and anxiety would engage 
in more communication with their PCPs about their pain, mental health and opioid 
safety, and opioid prescriptions. We also hypothesized that PCPs who were 
psychosocially oriented would talk more about pain, mental health and opioid safety, 
and opioids, while PCPs who reported an unwillingness or wariness to prescribe opioids 
and who reported higher levels of burnout would be less likely to engage in those 
conversations.  
2. Method 
2.1. Study Design  
2.1.1.  
We conducted a longitudinal, observational study to examine clinical 
communication about opioids and pain management with patients diagnosed with 
chronic non-cancer pain. We audio-recorded up to three appointments between patients 
and their PCPs. Patients and PCPs also completed questionnaires. 
2.1.2. Setting and Participants 
We conducted the study in four of the nine primary care clinics at an academic 
medical center serving mostly patients of lower socioeconomic status in Indiana (US). 
The institutional review board approved the study and all participants signed informed 
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consent; patients also signed a HIPAA (Health Insurance Portability and Accountability 
Act) agreement to allow access to protected health data. At the time of data collection, 
Indiana law required a signed opioid treatment agreement from patients. Physicians 
were also required to check, at least yearly, the state’s prescription drug monitoring 
program to determine whether the patient was receiving opioids from other prescribers, 
and to see patients prescribed >60 opioid-containing pills per month every 4 
months.[20]  
 
2.1.3. Eligibility  
PCPs were eligible to participate if they had patients with chronic non-cancer 
pain for whom they prescribed opioids. Eligible patients met the following criteria: 1) > 
18 years of age; 2) patient of enrolled PCP; 3) had chronic musculoskeletal pain 
(defined by ICD-9 codes: 715, 719, 721, 722, 723, 724, 726, 729.0, 729.1, 729.3, 729.5, 
738.4, 738.5) persisting for ≥ 3 months; 4) taking a prescribed opioid for pain at the time 
of enrollment; and 5) speaks English with their PCP.  We did not exclude patients who 
had other diagnoses as long as they met eligibility requirements. 
2.2. Recruitment 
Eligible patients were mailed a letter describing the study and were called within 
two weeks. Interested patients met with study staff in the clinic waiting room before their 
next PCP appointment; staff explained the study, answered questions, and obtained 
informed consent from those who agreed to participate.  
2.3. Data Collection Procedures 
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We collected data over 20 months (August 2015 - November 2016). Prior to 
appointments, research staff placed an audio recorder in the exam room and waited 
outside the room during the visit. Recorders were collected at the end of visits, and 
arrangements were made for recording the patient’s next PCP visit. Recordings were 
transcribed, de-identified, and checked for accuracy. Questionnaires were administered 
to patients before or after their first recorded visit; questionnaires were mailed to PCPs 
and they filled them out at their convenience. 
2.4. Measures 
2.4.1. Communication measures.  
We developed a coding system, adapted from an existing coding scheme,[21,22] 
to capture clinician-patient communication about pain management that consisted of 43 
initial items. We applied the coding system to our data and eliminated codes not used 
consistently (e.g., discussions of addiction, education, and breakthrough pain). We then 
conducted a factor analysis to examine the factor structure of the coding system. We 
found two factors: 1) opioid and pain management talk and 2) mental health and opioid 
safety talk (see Table 1). The opioid and pain management talk variable included items 
such as pain description, physical functioning, opioid refill requests, and non-opioid 
treatment options. The opioid safety and mental health talk variable included items such 
as depression/anxiety symptoms, psychiatric medication use, suicide risk/safety, opioid 
use frequency, and effectiveness of opioids. We measured the breadth of PCP-patient 
talk about these variables. We calculated scores for each patient visit with each PCP 
separately; thus, the individual visit was the unit of analysis, and we coded for the 
presence of talk about each of these topics.  
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2.4.2. Transcript coding.  
Each time patients or PCPs brought up a topic in the coding scheme; coders 
noted its occurrence in an Excel file. This file contained codes in drop-down lists parallel 
to each line of the transcript. The transcript was divided into sentences and, if needed, 
independent phrases, for units of analysis. Trained coders read each transcript and 
assigned a code to any line of the transcript that contained one of the topics in the 
coding manual. One-third of transcripts were double-coded for reliability. We provided 
coders with a manual that described the items above for opioid and pain management 
and mental health and opioid safety. We also provided coders with a list of opioid 
medications, non-opioid medications used to treat pain (e.g., non-steroidal anti-
inflammatory medications, neuropathic pain medications), and a list of prescription 
medications for depression and anxiety to reference during coding so that they could 
code medication discussions accurately. We did not code antidepressants or anti-
anxiety medications as treatments for pain management, but we did code them with a 
depression/anxiety code under the mental health and opioid safety variable.   
2.5. Independent Variables 
2.5.1. PCP characteristics.  
We assessed provider demographics including age, gender, race, and years in 
practice. We measured PCP burnout with the total mean score of the Maslach Burnout 
Inventory (MBI),[23,24]  which is widely used and validated with healthcare personnel. 
We assessed PCPs’ psychosocial orientation using the 6-item Burden subscale of the 
Physician Belief Scale,[25,26] with reverse-coded items so that higher scores indicated 
greater psychosocial orientation. We measured PCP negativity toward opioids using a 
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three-item measure asking about concerns and reluctance to prescribe opioids, which 
was developed for a previous study.[27]  
2.5.2. Patient characteristics.  
We collected patient demographics (gender, age, race, and education). Patients 
completed the Pain Catastrophizing Scale, which consists of 13 items that assessed 
three dimensions of catastrophizing: rumination, magnification, and helplessness, and 
has acceptable reliability and validity.[28,29] We assessed anxiety using the GAD-7, a 
brief measure of anxiety,[30] and pain intensity and interference with the three-item PEG 
(Pain, Enjoyment, General Activity).[31] We assessed patients’ perceptions of their 
therapeutic alliance with their PCPs with the 12-item Working Alliance Inventory (WAI) 
short form.[32,33] The WAI evaluates patient-provider agreement on treatment goals, 
collaboration to achieve these goals, and degree of emotional bond (liking and trust) 
between patients and providers. 
2.6. Data Analysis 
Each Excel coding sheet was imported into SAS 9.4 to calculate communication 
scores. We created scales to indicate the breadth of conversation about opioid and pain 
management and mental health and opioid safety talk. To calculate total scores, we 
limited individual item scores to three points. In scoring this way, higher scores indicated 
greater breadth of talk about opioid and pain management, rather a higher frequency of 
items.  
We examined demographic variables and distributions of study variables. We 
used mixed-model linear and logistic regression to account for the nesting of patients 
within PCPs. We standardized independent variables when appropriate for 
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interpretability. With our sample size, we were able to detect an effect size (Cohen’s d) 
of 0.42 with alpha set at .05 and power at 0.80. For the logistic regression, we estimated 
we had about 80% power to detect an odds ratio as small as 2.00. We did not adjust for 
multiple comparisons because such adjustments can obscure potential findings in 
exploratory contexts.[34] Finally, we examined the effects of multiple visits. We report 
the best fitting models based on Bayesian and Akaike’s Information Criteria. 
3. RESULTS 
3.1. Demographic and Descriptive Statistics 
Nine PCPs and 37 patients participated in the study. Results are presented for the 
eight PCPs and 30 patients who had complete questionnaire data. Seventy-eight 
primary care visits were recorded for these 30 patients; the average number of visits per 
patient was 2.67 (SD = .66). See Table 2 for demographics.  
The opioid and pain management talk variable mean was 19.80 (SD = 12.49). 
The measure was internally consistent (alpha = .72) and was coded reliably (ICC = 
0.72). The mental health and opioid safety talk variable mean was 0.16 (SD = 0.41). 
This measure was internally consistent (alpha = 0.86) and was coded reliably (ICC = 
0.69). The variables were independent of each other (r = 0.04). Table 3 shows the 
correlations of opioid and pain management talk and mental health and opioid safety 
talk with patient and PCP variables. PCPs and patients had more opioid and pain 
management talk when patients reported more pain (r = 0.30, p < 0.05) and pain 
catastrophizing (r = 0.39, p < 0.05), when patients were female (r = 0.22, p < 0.05), and 
when their PCPs reported a more psychosocial orientation (r = 0.25, p < 0.05). Mental 
health and opioid safety talk was highly skewed; thus, we dichotomized the variable for 
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analysis. Only 39% of cases had any mental health and safety talk. PCPs and patients 
discussed safety and mental health talk when patients reported more anxiety (r = 0.23, 
p < 0.05) and PCPs reported more burnout (r = .31, p < 0.05). PCPs and patients were 
less likely to discuss safety and mental health talk when PCPs reported more negative 
attitudes toward opioids (r = -0.24, p < 0.05). 
3.2. Opioid and Pain Management Talk  
We then conducted a mixed-model linear regression for opioid and pain 
management talk, controlling for nesting of patients within PCPs. We standardized all 
variables in the model except for years in practice. Table 4 shows that opioid and pain 
management talk was more extensive when patients reported more pain catastrophizing 
(β= 4.78, C.I. 1.77 – 7.78; p < .001) and when PCPs reported a more psychosocial 
orientation (β= 3.49, C.I. 0.60 – 6.40; p < .05). The longitudinal effect, visit occasion, 
was non-significant and had no effect on the other parameters in the model. Entering 
only the visit occasions into a model produced no significant differences between 
measurement times (not shown in tables). 
3.3. Opioid Safety and Mental Health Talk 
Finally, we conducted a mixed-model logistic regression (Table 5) on the opioid 
safety and mental health talk variable, controlling for the nesting of patients within 
PCPs. We found that when patients reported more anxiety there was a higher likelihood 
of talking about opioid safety and mental health (OR = 2.59, C.I. 1.21 – 5.53; p < .05). 
When patients reported more working alliance with their PCP there was an increased 
likelihood of opioid safety/mental health talk (OR = 2.14, CI 1.05 – 4.34; p < .05). More 
PCP-reported burnout was associated with an increased likelihood of mental health and 
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opioid safety talk (OR = 2.46, C.I. 1.27 – 4.77; p < .001). Finally, the more negativity 
PCPs reported toward opioids the less likely were clinician and patient to talk about 
opioid safety and mental health (OR = 0.32, C.I. 0.14 – 0.75; p < .001). Again, we 
examined the longitudinal effect across visits and found non-significant effects and no 
effect on the value of the other parameters in the model (not shown in tables). 
4. Discussion and Conclusions 
 
4.1. Discussion 
The current study examined the relationship between provider and patient 
characteristics and clinical communication about pain management, including 
communication about opioids, mental health, and opioid safety. In bivariate analyses, 
we found that greater patient pain catastrophizing and higher PCP psychosocial 
orientation were associated with more discussion about opioid and pain management. 
We also found greater patient anxiety and patient-PCP working alliance, as well as 
PCP-reported burnout, were associated with greater likelihood of opioid safety and 
mental health talk, while PCP negativity toward prescribing opioids was associated with 
lower likelihood of discussions about opioid safety and mental health.  
 Patients who reported higher levels of catastrophizing engaged in more opioid 
and pain management talk. Catastrophizing assesses patients’ appraisals of pain and 
their perceived ability to manage it.[28,29] Patients who report higher levels of 
catastrophizing are typically ruminating, magnifying, and feeling helpless in the face of 
their pain. It is possible that those appraisals led patients to engage in more talk about 
their pain and opioid prescription concerns.  
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 PCPs with higher psychosocial orientation talked more with patients about 
opioids and pain management. Physicians frequently describe patients with chronic pain 
as difficult and demanding,[16] but physicians with higher psychosocial orientations rate 
fewer patients as difficult[35] and respond to patients with more empathy.[36] Some 
evidence suggests that communication training can increase psychosocial orientation 
and improve communication skills.[37] A study by Jenkins and Fallowfield[37] indicated 
that psychosocial orientation may be a modifiable factor to improve PCP-patient 
communication about opioids and pain management.  
 Providers brought up mental health and opioid safety concerns in 39% of 
encounters. Patient anxiety and patient-reported working alliance were both associated 
with PCPs and patients talking more about mental health and opioid safety. Working 
alliance assesses patient-provider agreement on treatment goals, collaboration to 
achieve goals, and emotional bond. A strong working alliance is important in treating 
chronic pain,[38,39] especially with the uncertainties associated with pain treatments 
such as opioids.[14] Given the inherent risks of opioids and the widely reported 
increases in opioid-related harms, it is not surprising that PCPs would be concerned 
about opioid safety. This may be especially true if patients are suffering from mental 
health concerns, such as depression, which could place them at greater risk of opioid-
related harms. Having a strong working alliance may also help to facilitate these 
potentially difficult conversations.   
 Contrary to our hypothesis, PCPs with higher burnout talked more about mental 
health and opioid safety. While this may appear counterintuitive, other studies have 
found similar results. In a study evaluating internal medicine residents, Beckman and 
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colleagues found that higher burnout was associated with clinical supervisors rating 
residents higher on communication skills.[40] In another study, residents who reported 
burnout were rated by patients as more empathetic and encouraging.[41] These studies’ 
authors suggested that burnout may be associated with higher levels of professional 
achievement, including placing professional duties, such as communicating with 
patients and displaying empathy, above all other priorities. While such behaviors may 
be perceived positively by patients, a large body of work shows detrimental effects of 
burnout on both providers and patients.[42] In practicing physicians, Ratanawongsa and 
colleagues[43] found that higher physician burnout was associated with more negative 
patient rapport building statements such as direct and indirect disagreement and 
criticism.  
We found that PCPs with negative attitudes about prescribing opioids were less 
likely to talk to patients about mental health or opioid safety issues. Prior research 
indicates that patients and providers frequently struggle with communication related to 
chronic pain, especially when discussions involve opioids.[39,44–46] These struggles 
may be especially problematic for providers who have more concerns about opioids, 
potentially leading them to avoid any discussions related to opioids, even if such 
discussions relate to safety or mental health issues.  
This study has some limitations. We had a relatively small sample of PCPs and 
patients. One PCP was a physician’s assistant, with differing training and licensing from 
the other PCPs. Most PCPs were female and White; patients were mostly female and of 
low socioeconomic status. In addition, our data collection was conducted at a single 
academic medical center. These factors suggest that findings might not generalize to 
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other medical settings and to patients and PCPs with different demographics. The 
coding system used for clinical encounters, while coded with acceptable reliability, was 
adapted specifically for this study and thus has not been validated in other studies. 
Patient questionnaires were administered at different times, either before or after the 
first recorded visit, depending on when patients arrived for their appointment. While this 
introduces some variability into the data, we believe it is unlikely to have an effect on 
results because the patient-provider relationships were longitudinal and none of the 
recorded visits were first visits. Finally, although we observed up to three medical 
encounters per patient, we were not able to capture the full range of ongoing chronic 
pain management, including initial pain assessment and diagnosis, and initiation of 
opioids for these patients.  
Despite these limitations, this study is the first we are aware of that directly 
analyzed patient-provider communication about pain and opioid management across 
multiple primary care visits. While other studies have analyzed clinical communication 
cross-sectionally,[14,15,47–49] a longer-term examination of clinical communication 
about opioids is important because chronic pain is managed over time; thus 
assessment of a single visit would likely miss crucial aspects of pain management. 
While analyzing multiple visits does not capture the entire course of a patient’s pain 
management, as we have acknowledged in the limitations, it does allow us to capture a 
broader range of pain management topics discussed in primary care visits. In addition, 
the study sample was racially diverse, with Black patients comprising almost half of the 
sample. This is potentially important because racial disparities persist in healthcare, 
particularly in pain treatment.[50–52] Learning more about communication with a racially 
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diverse sample affords the opportunity to understand a wider range of communication 
behaviors, especially challenges, which may inform future interventions to improve pain 
management communication for all patients. 
4.2. Conclusion 
Study findings revealed several patient and provider factors associated with pain 
and opioid management, opioid safety, and mental health conversations. Future 
research should seek greater understanding of the complexity of these relationships 
and their association with outcomes, including patient and provider experiences, 
implementation of the treatment plan, and, ultimately, improved clinical outcomes for 
patients.[17] Because communication is central to effective pain management, including 
assessment, formulation, and evaluation of a treatment plan, and modification of the 
plan as needed, studies that seek to understand and improve this communication are 
essential for improving clinical outcomes for patients with chronic pain.  
4.3. Practice Implications 
Providers treating patients with chronic pain are under increased scrutiny of their opioid 
prescribing practices.[53] Our study provides clues to patient and provider 
characteristics that may be related to the level of engagement of patients and providers 
in important discussions about the role of opioids in pain management and the mental 
health and safety concerns raised by opioid medications. Our results suggest that 
providers should be aware of how their own biases toward opioids, opioid prescribing, 
and addiction may influence the conversations they have with patients.  
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Table 1  
Provider and Patient Codes 
Variable 
Factor 
Loading 
M SD Min Max 
      
Opioid & Pain Management Talk      
Provider      
Pain = patients’ pain is discussed 0.73 3.83 4.95 0 31 
Other treatment = other pain treatment options 
discussed e.g. physical therapy, exercise, 
massage 0.58 4.13 5.26 0 33 
Function = discusses what makes pain better or 
worse 0.45 0.65 1.25 0 8 
Referrals = are made to pain specialists or clinics   0.23 0.13 0.43 0 4 
Refill = refills opioid without changing dosage 0.23 0.42 0.69 0 4 
 
     
Patient      
Pain = patient discusses their pain  0.74 5.83 6.16 0 49 
Function = discusses what makes pain better or 
worse 0.51 1.73 2.51 0 17 
Other treatment = other treatment options 
discussed 0.45 2.5 3.31 0 18 
Opioid requests = requests for refill of current 
opioid or for a new opioid 0.22 0.24 0.63 0 5 
 
     
Opioid Safety & Mental Health Talk      
Provider      
Depression/anxiety = asks about/discusses 
patient’s depression or anxiety symptoms 0.71 0.57 1.58 0 15 
Suicide Safety = asks about suicidal ideation, 
intentions, and safety plans (in which patients 
and providers discuss action plans if patient 
feels suicidal) 0.65 0.12 0.71 0 7 
Opioid frequency = Asks about frequency of 
opioid use 0.55 2.28 2.96 0 16 
Efficacy = asks if opioid is working to relieve pain 0.46 0.60 0.94 0 5 
Goals = discusses how much pain control can be 
obtained and goals of use of opioids 0.45 0.55 1.86 0 12 
Decrease = decides to decrease opioid dosage 0.27 0.31 1.05 0 7 
Psych Meds = asks about or discusses 
psychiatric medications 0.27 0.87 2.03 0 14 
 
     
Patient      
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Opioid frequency = discusses the frequency of 
opioid use 0.62 2.44 2.81 0 15 
Depression/anxiety = asks about/discusses 
depression or anxiety symptoms 0.59 0.68 1.88 0 16 
OTC  = discusses the use of any over-the-
counter medication for pain control 0.51 1.42 2.34 0 14 
Psych Meds = asks about/discusses psychiatric 
medications 0.34 0.98 2.13 0 12 
Opioid Information Seeking = asking informative 
questions about opioids (that are not seeking an 
opioid increase/decrease/refill)  0.31 1.67 2.1 0 16 
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Table 2 
Study Variables and Patient and Physician Demographics 
 Mean/% Std. Dev. 
Coded Communication from Transcripts (N=78)   
 Opioid and Pain Management  19.80 12.49 
 Mental Health and Safety (1 = discussed, 0 = not discussed) 0.16 / 39% 0.41 
   
Patient Demographics (N=30)   
 Age 58.80 11.07 
 Female  67%  
 High School or less 67%  
 Black 43%  
 Employed Full Time 17%  
   
Patient Characteristics    
 Pain Catastrophizing 24.37 14.80 
 Anxiety 6.9 5.50 
 Alliance with Physician 74.67 13.52 
 PEG  20.5 7.14 
   
Physician Demographics (N=8)   
 Female  88%  
 White 75%  
 Age 42.88 8.89 
 Years in Practice 15.86 10.16 
Clinicians: Internal Medicine = 5, Family  
  Medicine =  2, Physician Assistant = 1   Total = 8  
   
Physician Characteristics    
 Psychosocial Orientation 1.46 0.43 
 Burnout 2.06 0.76 
 Negative toward Opioids 4.50 0.62 
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Table 3  
Correlations of Opioid and Pain Management Talk (OPMT) and Opioid Safety and Mental Health (OSMT) with Patient and 
Physician Characteristics (N=78) 
 OPMT 2 3 4 5 6 7 8 9 10 11 12 13 
2 OSMT -0.01             
              
Patient Variables              
3 PEG 0.30 0.00            
4 Catastrophizing 0.39 0.00 0.58           
5 Anxiety 0.18 0.23 0.48 0.71          
6 Depression 0.21 0.10 0.66 0.68 0.79         
7 Alliance -0.03 -0.05 -0.21 -0.19 -0.29 -0.31        
8 Black 0.15 -0.06 0.43 0.32 0.23 0.26 0.29       
9 Female 0.22 0.04 0.36 0.32 0.44 0.42 -0.10 0.29      
10 Age -0.13 0.01 -0.43 -0.45 -0.49 -0.57 0.16 -0.29 -0.22     
              
Physician Variables              
11 Negative toward Opioids 0.19 -0.24 0.20 0.10 -0.02 0.07 0.38 0.10 -0.15 -0.10    
12 Years of Practice -0.05 -0.03 0.02 -0.10 -0.10 -0.11 -0.12 -0.04 0.11 0.27 -0.41   
13 Psychosocial Orientation 0.25 -0.11 -0.09 -0.14 -0.28 -0.27 -0.31 -0.11 -0.14 -0.36 -0.50 0.04  
14 Burnout -0.03 0.31 0.11 0.04 0.25 0.26 -0.34 0.07 0.03 0.00 -0.31 -0.04 -0.43 
 Bolded correlations are significant at p < .05. (N=78) 
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Table 4  
Mixed Model Regression on Opioid and Pain Management Talk (N=78) 
 
B  95% C.I. 
Patient Variables     
 Catastrophizing 4.78 ** 1.77 7.78 
 PEG 1.12  -1.86 4.12 
Physician Variables     
 Burnout 0.46  -2.26 3.18 
 Years of Practice 0.00  -0.24 0.25 
 Psychosocial Orientation 3.49 * 0.60 6.40 
* p < 0.05, **p < 0.001   
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Table 5  
Mixed Model Logistic Regression on Mental Health and Safety Talk (N=78) 
 
 OR  95% C.I.  
Patient Variables     
Anxiety 2.59 * 1.21 5.53 
Alliance with Physician 2.14 * 1.05 4.34 
Physician Variables     
Burnout 2.46 ** 1.27 4.77 
Psychosocial Orientation 1.91  0.88 4.18 
Negative toward Opioids 0.32 ** 0.14 0.75 
     
* p < 0.05, **p < 0.001  
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